股本结构
单位：万股
| 公告日期 | 2024-04-23 | 2024-04-23 | 2024-02-15 | 2024-02-15 | 2024-02-07 | 2024-03-21 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3325.69 | 3252.26 | 1199.00 | 419.50 | 341.63 | 341.59 |
| 普通股本 | 3325.69 | 3252.26 | 1199.00 | 419.50 | 341.63 | 341.59 |
| 优先股 | 未披露 | 1.58 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-27 | 2024-03-14 | 2024-02-15 | 2024-02-08 | 2024-02-05 | 2023-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-23 | 3325.69 | 未披露 | 定期报告 | 2024-03-27 |
| 2024-04-23 | 3252.26 | 1.58 | 定期报告 | 2024-03-14 |
| 2024-02-15 | 1199.00 | 未披露 |
更多>>
Common stock offered 7,795,000 shares by the company
|
2024-02-15 |
| 2024-02-15 | 419.50 | 未披露 | 定期报告 | 2024-02-08 |
| 2024-02-07 | 341.63 | 未披露 | 定期报告 | 2024-02-05 |
| 2024-01-19 | 341.59 | 未披露 | 定期报告 | 2024-01-19 |
| 2024-03-21 | 341.59 | 2.00 |
更多>>
From December 31,2022 to December 31,2023
Exercise of common stock warrants
Issuance of stock from RSUs, net
Conversion of Series J Convertible Redeemable Preferred Stock
Conversion of Series H Convertible Redeemable Preferred Stock
Sale of common stock and pre-funded warrants, net of fees
|
2023-12-31 |
| 2023-12-26 | 341.59 | 未披露 | 定期报告 | 2023-12-15 |
| 2023-12-08 | 341.50 | 未披露 |
更多>>
Securities offered 331,000 shares by the company
|
2023-12-08 |
| 2023-12-08 | 308.40 | 未披露 | 定期报告 | 2023-12-06 |
| 2023-11-09 | 229.68 | 未披露 | 定期报告 | 2023-11-02 |
| 2023-11-09 | 226.60 | 0.0043 |
更多>>
From June 30, 2023 to September 30, 2023
Conversion of Series H Convertible Preferred Stock
Redemption of Series I Redeemable Preferred Stock
Issuance of Series J Convertible Preferred Stock, net of fees
Exercise of Series J Convertible Preferred Stock Warrants
Conversion of Series J Convertible Preferred Stock
|
2023-09-30 |
| 2023-09-15 | 104.38 | 0.50 | 定期报告 | 2023-08-25 |
| 2023-08-10 | 104.37 | 未披露 | 定期报告 | 2023-08-03 |
| 2023-07-26 | 104.00 | 未披露 |
更多>>
Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company’s common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.
|
2023-07-28 |
| 2023-06-21 | 8536.70 | 未披露 | 定期报告 | 2023-06-20 |
| 2023-05-24 | 3130.19 | 未披露 | 定期报告 | 2023-05-12 |
| 2023-05-11 | 2773.41 | 未披露 | 定期报告 | 2023-05-04 |
| 2023-05-11 | 2632.70 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of stock from RSUs, net
Sale of common stock and pre-funded warrants, net of fees
Exercise of common stock warrants
|
2023-03-31 |
| 2023-03-28 | 2632.67 | 未披露 | 定期报告 | 2023-03-21 |
| 2023-03-29 | 2489.99 | 未披露 | 定期报告 | 2023-03-14 |
| 2023-03-29 | 2489.79 | 未披露 | 定期报告 | 2023-03-07 |
| 2023-01-11 | 2417.45 | 未披露 |
更多>>
16,453,569 shares offered by the company
|
2023-01-12 |
| 2023-03-28 | 772.10 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of restricted shares
Redemption of Series G Redeemable Preferred Stock
Issuance of stock from RSUs, net
Sale of common stock, net
Conversion of Series F Convertible Preferred Stock
Exercise of common stock warrants
Issuance of Series G Redeemable Preferred Stock
|
2022-12-31 |
| 2023-01-11 | 772.09 | 未披露 | 定期报告 | 2022-12-29 |
| 2022-11-10 | 714.55 | 未披露 | 定期报告 | 2022-11-03 |
| 2022-11-10 | 714.20 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of stock from RSUs, net
Exercise of common stock warrants
|
2022-09-30 |
| 2022-08-08 | 685.48 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-11 | 685.50 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Sale of common stock, net of fees
Issuance of stock from RSUs, net
Redemption of Series G Redeemable Preferred Stock
|
2022-06-30 |
| 2022-05-12 | 617.40 | 未披露 | 定期报告 | 2022-05-05 |
| 2022-04-28 | 620.00 | 未披露 |
更多>>
BIOLASE, Inc. announced a 1-for-25 reverse stock split that will become effective at 11:59 p.m. Eastern Time on April 28, 2022, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on April 29, 2022. The 1-for-25 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 154 million shares to approximately 6.2 million shares.
|
2022-04-29 |
| 2022-03-30 | 15434.57 | 未披露 | 定期报告 | 2022-03-29 |
| 2022-03-17 | 15434.07 | 未披露 | 定期报告 | 2022-03-10 |
| 2022-03-17 | 15367.60 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Sale of common stock, net
Exercise of stock options, net
Issuance of common stock for settlement of liability
Issuance of restricted shares
Conversion of Series F Convertible Preferred Stock
Deemed dividend on Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
|
2021-12-31 |
| 2021-11-10 | 15327.95 | 未披露 | 定期报告 | 2021-11-04 |
| 2021-10-08 | 15301.70 | 未披露 | 定期报告 | 2021-10-01 |
| 2021-11-10 | 15327.70 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock option
Issuance of restricted shares
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
Deemed dividend on Series F Convertible Preferred Stock
|
2021-09-30 |
| 2021-08-13 | 15119.36 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-13 | 15119.10 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
|
2021-06-30 |
| 2021-05-13 | 15039.92 | 未披露 | 定期报告 | 2021-05-04 |
| 2021-04-19 | 15055.55 | 未披露 | 定期报告 | 2021-04-14 |
| 2021-04-19 | 14938.24 | 未披露 | 定期报告 | 2021-04-01 |
| 2021-05-13 | 14938.20 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Sale of common stock
Issuance of common stock for settlement of liability
Conversion of Series F Convertible Preferred Stock
Exercise of common stock warrants
|
2021-03-31 |
| 2021-03-31 | 14937.99 | 未披露 | 定期报告 | 2021-03-25 |
| 2021-02-10 | 14598.18 | 未披露 |
更多>>
1.Common stock offered by the company 14,000,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 131,981,769 shares of common stock outstanding as of February 5, 2021.
|
2021-02-10 |
| 2021-02-09 | 13198.18 | 0.03 | 定期报告 | 2021-02-05 |
| 2021-01-26 | 12515.50 | 未披露 | 定期报告 | 2021-01-25 |
| 2021-03-31 | 9766.34 | 0.10 |
更多>>
From December 31, 2019 to December 31, 2020
Conversion of Series E Participating Convertible Preferred Stock
Sale of common stock
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
|
2020-12-31 |
| 2020-12-11 | 9350.99 | 未披露 | 定期报告 | 2020-12-10 |
| 2020-12-15 | 9301.42 | 0.11 | 定期报告 | 2020-11-10 |
| 2020-11-13 | 9299.90 | 0.10 |
更多>>
From June 30, 2020 to September 30, 2020
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of June 2020 Warrants
Issuance of Series F Convertible Preferred Stock in Rights Offering,net of $0.3 million in offering costs
Beneficial conversion on Series F Convertible Preferred Stock
Deemed dividend on Series F Convertible Preferred Stock
|
2020-09-30 |
| 2020-08-14 | 9219.06 | 未披露 | 定期报告 | 2020-08-11 |
| 2020-07-24 | 5034.21 | 1.80 | 定期报告 | 2020-07-21 |
| 2020-08-14 | 5034.20 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock
Conversion of redeemable preferred stock
|
2020-06-30 |
| 2020-06-19 | 5034.21 | 未披露 | 定期报告 | 2020-06-17 |
| 2020-06-10 | 5038.51 | 未披露 |
更多>>
1.Common stock offered by the company in this offering 10,800,000 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 39,585,113 shares outstanding as of June 1, 2020.
|
2020-06-10 |
| 2020-06-03 | 3958.51 | 3954.00 | 定期报告 | 2020-06-01 |
| 2020-05-08 | 3174.31 | 未披露 | 定期报告 | 2020-05-04 |
| 2020-05-08 | 3153.70 | 7.00 |
更多>>
From December 31, 2019 to March 31, 2020
Settlement of liability awards
Stock-based compensation expense
|
2020-03-31 |
| 2020-03-30 | 3157.75 | 6.96 | 定期报告 | 2020-03-20 |
| 2020-04-23 | 3153.24 | 未披露 | 定期报告 | 2020-03-18 |
| 2020-03-30 | 3143.90 | 7.00 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of Series E Convertible Preferred Stock, net of issuance costs of $35
Exercise of stock options, net
Issuance of Common Stock in public offering, net of issuance costs of $920
Issuance of stock from RSUs, net
|
2019-12-31 |
| 2019-11-12 | 3094.74 | 未披露 | 定期报告 | 2019-11-06 |
| 2019-10-29 | 2977.44 | 未披露 | 定期报告 | 2019-10-29 |
| 2019-11-12 | 2195.44 | 未披露 | 定期报告 | 2019-09-30 |
| 2019-08-09 | 2186.62 | 未披露 | 定期报告 | 2019-08-07 |
| 2019-08-09 | 2187.96 | 未披露 | 定期报告 | 2019-07-31 |
| 2019-08-09 | 2186.60 | 未披露 | 定期报告 | 2019-06-30 |
| 2019-04-10 | 2129.37 | 未披露 | 定期报告 | 2019-04-01 |
| 2019-05-10 | 2129.40 | 未披露 | 定期报告 | 2019-03-31 |
| 2019-03-08 | 2112.62 | 未披露 | 定期报告 | 2019-03-05 |
| 2019-03-08 | 2107.25 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Issuance of stock from RSUs, net
|
2018-12-31 |
| 2018-11-14 | 2065.49 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-13 | 2059.69 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-11 | 2047.00 | 未披露 |
更多>>
The 1-for-5 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 102,380,238 shares to approximately 20,470,047 shares.Immediately after the annual meeting, the Board of Directors approved the reverse stock split of BIOLASE's common stock, through an amendment to BIOLASE's charter, at a ratio of 1 post-split share for every 5 pre-split shares. The 1-for-5 reverse stock split will become effective at 11:59 p.m. ET on Thursday, May 10, 2018 (the "Effective Date"), and Company common stock will begin trading on a split-adjusted basis at the opening of the market on May 11, 2018.
|
2018-05-11 |
| 2018-05-04 | 10238.02 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-04-05 | 10235.02 | 未披露 | 定期报告 | 2018-03-21 |
| 2018-03-14 | 10234.47 | 未披露 | 定期报告 | 2018-03-07 |
| 2018-01-16 | 10233.97 | 未披露 |
更多>>
On September 29, 2017, we filed a registration statement on Form S-1 with the SEC for a rights offering in which our existing stockholders were to receive non-transferable subscription rights to purchase up to $12.0 million of additional shares of our common stock. The registration statement for the rights offering was declared effective on November 8, 2017 by the SEC. We completed the rights offering on December 5, 2017 and raised approximately $12.0 million by selling 26,302,703 shares of our common stock at the $0.456 per share offering price. As a result, the total number of shares of our common stock outstanding as of the completion of the rights offering was approximately 102,339,682 shares.
|
2018-01-09 |
| 2018-03-14 | 10234.00 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of stock from RSUs, net
Issuance of common stock upon conversion of Series D participating convertible preferred stock
Issuance of stock from rights offering, net
Issuance of Series D participating convertible preferred stock and warrants, net of issuance cost of $251
|
2017-12-31 |
| 2017-11-01 | 7601.94 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-09-29 | 7601.94 | 未披露 | 定期报告 | 2017-09-22 |
| 2017-08-07 | 7597.68 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-19 | 6791.24 | 未披露 | 定期报告 | 2017-05-18 |
| 2017-05-04 | 6766.07 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-10 | 6757.10 | 未披露 | 定期报告 | 2017-03-06 |
| 2017-03-10 | 6756.60 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of common stock upon conversion of Series C participating convertible preferred stock
Issuance of stock from RSUs, net
Issuance of Series C participating convertible preferred stock and warrants, net of issuance cost of $480
|
2016-12-31 |
| 2016-10-27 | 6756.60 | 未披露 | 定期报告 | 2016-10-21 |
| 2016-11-08 | 6756.60 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-09-07 | 5871.66 | 未披露 | 定期报告 | 2016-09-01 |
| 2016-08-01 | 5825.73 | 未披露 | 定期报告 | 2016-07-29 |
| 2016-08-01 | 5825.70 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-09 | 5825.73 | 未披露 | 定期报告 | 2016-05-02 |
| 2016-05-09 | 5825.70 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-11 | 5822.75 | 未披露 | 定期报告 | 2016-02-29 |
| 2016-03-11 | 5822.80 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Exercise of stock options, net
|
2015-12-31 |
| 2015-11-06 | 5822.75 | 未披露 | 定期报告 | 2015-10-30 |
| 2015-11-06 | 5822.80 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-07 | 5819.07 | 未披露 | 定期报告 | 2015-07-31 |
| 2015-08-07 | 5818.80 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-01 | 5815.28 | 未披露 | 定期报告 | 2015-04-27 |
| 2015-05-01 | 5815.30 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-06 | 5815.28 | 未披露 | 定期报告 | 2015-02-27 |
| 2015-03-06 | 5811.50 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Exercise of stock options, net
Retirement of treasury stock
Issuance of stock, net
Exercise of warrants
Stock dividends
|
2014-12-31 |
| 2014-11-26 | 5811.50 | 未披露 | 定期报告 | 2014-11-21 |
| 2014-11-07 | 4395.21 | 未披露 | 定期报告 | 2014-10-31 |
| 2014-11-07 | 4395.20 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-08-21 | 4389.90 | 未披露 | 定期报告 | 2014-08-14 |
| 2014-07-29 | 4388.65 | 未披露 | 定期报告 | 2014-07-22 |
| 2014-08-08 | 3763.60 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-04-30 | 3762.65 | 未披露 | 定期报告 | 2014-04-28 |
| 2014-05-12 | 3762.60 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-05 | 3759.46 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2014-03-12 |
| 2014-03-17 | 3740.75 | 未披露 | 定期报告 | 2014-02-28 |
| 2014-03-17 | 3537.20 | 未披露 |
更多>>
From December 31,2012 to December 31,2013
Issuance of stock, net
Exercise of warrants
Stock dividends
|
2013-12-31 |
| 2013-12-05 | 3502.59 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2013-12-12 |
| 2013-11-12 | 3485.16 | 未披露 | 定期报告 | 2013-10-18 |
| 2013-11-12 | 3485.20 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-15 | 3413.05 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2013-08-28 |
| 2013-08-09 | 3396.07 | 未披露 | 定期报告 | 2013-08-02 |
| 2013-08-09 | 3199.50 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-05-21 | 3173.72 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2013-06-12 |
| 2013-04-30 | 3157.93 | 未披露 | 定期报告 | 2013-04-29 |
| 2013-05-10 | 3152.30 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-02-28 | 3150.04 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2013-03-13 |
| 2013-03-15 | 3134.37 | 未披露 | 定期报告 | 2013-03-08 |
| 2013-03-15 | 3324.80 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Exercise of stock options, net
Stock repurchase
Exercise of warrants
Stock dividends
|
2012-12-31 |
| 2012-12-03 | 3128.01 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2012-12-12 |
| 2012-11-09 | 3112.45 | 未披露 | 定期报告 | 2012-11-02 |
| 2012-11-09 | 3112.40 | 未披露 | 定期报告 | 2012-09-30 |
| 2012-08-28 | 3124.04 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2012-09-12 |
| 2012-08-09 | 3108.50 | 未披露 | 定期报告 | 2012-08-03 |
| 2012-08-09 | 3106.30 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-11 | 3103.39 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2012-06-06 |
| 2012-05-10 | 3087.95 | 未披露 | 定期报告 | 2012-05-04 |
| 2012-05-09 | 3080.50 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-03-05 | 3070.09 | 未披露 |
更多>>
Common stock dividend: 0.005 shares per share
|
2012-03-13 |
| 2012-03-13 | 3054.82 | 未披露 | 定期报告 | 2012-03-09 |
| 2012-03-09 | 3053.80 | 未披露 | 定期报告 | 2011-12-31 |
| 2011-11-15 | 3061.41 | 未披露 |
更多>>
Common stock dividend: 0.01 shares per share
|
2011-11-22 |
| 2011-11-10 | 3031.10 | 未披露 | 定期报告 | 2011-11-08 |
| 2011-11-10 | 3030.00 | 未披露 | 定期报告 | 2011-09-30 |
| 2011-08-22 | 3019.50 | 未披露 |
更多>>
Common stock dividend: 0.01 shares per share
|
2011-08-25 |
| 2011-08-11 | 2989.61 | 未披露 | 定期报告 | 2011-08-09 |
| 2011-08-10 | 2984.50 | 未披露 | 定期报告 | 2011-06-30 |
| 2011-06-01 | 2844.36 | 未披露 |
更多>>
Common stock dividend: 0.01 shares per share
|
2011-06-08 |
| 2011-05-10 | 2816.20 | 未披露 | 定期报告 | 2011-05-09 |
| 2011-05-10 | 2743.30 | 未披露 | 定期报告 | 2011-03-31 |
| 2011-03-23 | 2747.97 | 未披露 | 定期报告 | 2011-03-15 |
| 2011-01-20 | 2484.70 | 未披露 |
更多>>
Common stock dividend: 0.01 shares per share
|
2011-03-11 |
| 2011-03-23 | 2460.10 | 未披露 |
更多>>
Exercise of stock options, net
|
2010-12-31 |
| 2010-11-03 | 2458.46 | 未披露 | 定期报告 | 2010-10-29 |
| 2010-11-03 | 2454.30 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-08-16 | 2442.79 | 未披露 | 定期报告 | 2010-08-12 |
| 2010-08-16 | 2442.00 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-05-17 | 2438.88 | 未披露 | 定期报告 | 2010-05-12 |
| 2010-05-17 | 2438.70 | 未披露 | 定期报告 | 2010-03-31 |
| 2010-03-19 | 2438.49 | 未披露 | 定期报告 | 2010-03-17 |
| 2010-03-19 | 2437.60 | 未披露 |
更多>>
Exercise of stock options, net
|
2009-12-31 |
| 2009-03-16 | 2424.42 | 未披露 | 定期报告 | 2009-03-12 |
| 2009-03-16 | 2424.40 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Exercise of stock options, net
|
2008-12-31 |
| 2008-03-17 | 2412.44 | 未披露 | 定期报告 | 2008-03-12 |
| 2008-03-17 | 2400.30 | 未披露 |
更多>>
from December 31, 2006 to December 31, 2007
Exercise of stock options
|
2007-12-31 |
| 2007-03-16 | 2380.08 | 未披露 | 定期报告 | 2007-03-14 |
| 2007-03-16 | 2377.70 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Exercise of stock options
|
2006-12-31 |
| 2006-03-16 | 2328.90 | 未披露 | 定期报告 | 2006-03-09 |
| 2006-03-16 | 2325.40 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Exercise of stock options
Issuance of common stock
|
2005-12-31 |
| 2005-07-19 | 2297.59 | 未披露 | 定期报告 | 2005-05-31 |
| 2005-07-19 | 2251.85 | 未披露 |
更多>>
from December 31, 2003 to December 31, 2004
Exercise of stock options
Issuance of common stock
Treasury stock
|
2004-12-31 |
| 2004-03-03 | 2156.14 | 未披露 | 定期报告 | 2004-02-17 |
| 2004-03-03 | 2155.90 | 未披露 |
更多>>
from December 31, 2002 to December 31, 2003
Exercise of stock options
Exercise of warrants
Acquisition of ADL
|
2003-12-31 |
| 2003-03-24 | 2049.97 | 未披露 | 定期报告 | 2003-02-28 |
| 2003-03-24 | 2013.10 | 未披露 |
更多>>
from December 31, 2001 to December 31, 2002
Exercise of stock options
Exercise of warrants
|
2002-12-31 |
| 2002-04-01 | 1983.54 | 未披露 | 定期报告 | 2002-03-01 |
| 2002-04-01 | 1973.40 | 未披露 |
更多>>
from December 31, 2000 to December 31, 2001
Issuance of stock and warrants for earned services
Exercise of stock options
Exercise of warrants
|
2001-12-31 |
| 2001-04-02 | 1947.57 | 未披露 | 定期报告 | 2001-03-30 |
| 2001-04-02 | 1936.65 | 未披露 |
更多>>
from December 31, 1999 to December 31, 2000
Private placement of common stock, net
Issuance of stock and warrants for earned services
Cancellation of stock
Exercise of stock options
Issuance of shares for fractional interest on reverse split
|
2000-12-31 |
| 2000-04-14 | 1974.99 | 未披露 | 定期报告 | 2000-04-07 |
| 2000-04-14 | 1758.33 | 未披露 |
更多>>
from December 31, 1998 to December 31, 1999
Private placement of common stock, net
Issuance of stock and warrants for earned services
Exercise of stock options
Issuance of shares for fractional interest on reverse split
|
1999-12-31 |
| 1999-04-15 | 1765.74 | 未披露 | 定期报告 | 1999-03-31 |
| 1999-04-15 | 1631.20 | 未披露 |
更多>>
from December 31, 1997 to December 31, 1998
Private placement of common stock
Issuance of stock for Laser Skin Toner purchase
Issuance of stock and warrants for earned services
Exercise of stock options
Issuance of shares for fractional interest on reverse split
|
1998-12-31 |
| 1998-03-31 | 1346.26 | 未披露 |
更多>>
from December 31, 1996 to December 31, 1997
Private placement of common stock
Exercise of stock options
Issuance of stock primarily for services
Issuance of stock primarily for unearned services
Cancellation of previously issued stock
Conversion of preferred stock to common stock
Issuance of shares for fractional interest on reverse split
|
1997-12-31 |
| 1998-03-31 | 1312.99 | 0.0001 |
更多>>
from December 31, 1995 to December 31, 1996
Exercise of stock options
Conversion of preferred stock to common stock
Issuance of shares for fractional interest on reverse split
Private placement of preferred stock
|
1996-12-31 |
Common stock offered 7,795,000 shares by the company
From December 31,2022 to December 31,2023
Exercise of common stock warrants
Issuance of stock from RSUs, net
Conversion of Series J Convertible Redeemable Preferred Stock
Conversion of Series H Convertible Redeemable Preferred Stock
Sale of common stock and pre-funded warrants, net of fees
Securities offered 331,000 shares by the company
From June 30, 2023 to September 30, 2023
Conversion of Series H Convertible Preferred Stock
Redemption of Series I Redeemable Preferred Stock
Issuance of Series J Convertible Preferred Stock, net of fees
Exercise of Series J Convertible Preferred Stock Warrants
Conversion of Series J Convertible Preferred Stock
Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company’s common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.
From December 31, 2022 to March 31, 2023
Issuance of stock from RSUs, net
Sale of common stock and pre-funded warrants, net of fees
Exercise of common stock warrants
16,453,569 shares offered by the company
From December 31, 2021 to December 31, 2022
Issuance of restricted shares
Redemption of Series G Redeemable Preferred Stock
Issuance of stock from RSUs, net
Sale of common stock, net
Conversion of Series F Convertible Preferred Stock
Exercise of common stock warrants
Issuance of Series G Redeemable Preferred Stock
From June 30, 2022 to September 30, 2022
Issuance of stock from RSUs, net
Exercise of common stock warrants
From March 31, 2022 to June 30, 2022
Sale of common stock, net of fees
Issuance of stock from RSUs, net
Redemption of Series G Redeemable Preferred Stock
BIOLASE, Inc. announced a 1-for-25 reverse stock split that will become effective at 11:59 p.m. Eastern Time on April 28, 2022, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on April 29, 2022. The 1-for-25 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 154 million shares to approximately 6.2 million shares.
From December 31, 2020 to December 31, 2021
Sale of common stock, net
Exercise of stock options, net
Issuance of common stock for settlement of liability
Issuance of restricted shares
Conversion of Series F Convertible Preferred Stock
Deemed dividend on Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
From June 30, 2021 to September 30, 2021
Exercise of stock option
Issuance of restricted shares
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
Deemed dividend on Series F Convertible Preferred Stock
From March 31, 2021 to June 30, 2021
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
From December 31, 2020 To March 31, 2021
Sale of common stock
Issuance of common stock for settlement of liability
Conversion of Series F Convertible Preferred Stock
Exercise of common stock warrants
1.Common stock offered by the company 14,000,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 131,981,769 shares of common stock outstanding as of February 5, 2021.
From December 31, 2019 to December 31, 2020
Conversion of Series E Participating Convertible Preferred Stock
Sale of common stock
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of common stock warrants
From June 30, 2020 to September 30, 2020
Conversion of Series F Convertible Preferred Stock
Issuance of stock from RSUs, net
Exercise of June 2020 Warrants
Issuance of Series F Convertible Preferred Stock in Rights Offering,net of $0.3 million in offering costs
Beneficial conversion on Series F Convertible Preferred Stock
Deemed dividend on Series F Convertible Preferred Stock
From March 31, 2020 to June 30, 2020
Issuance of common stock
Conversion of redeemable preferred stock
1.Common stock offered by the company in this offering 10,800,000 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 39,585,113 shares outstanding as of June 1, 2020.
From December 31, 2019 to March 31, 2020
Settlement of liability awards
Stock-based compensation expense
From December 31, 2018 to December 31, 2019
Issuance of Series E Convertible Preferred Stock, net of issuance costs of $35
Exercise of stock options, net
Issuance of Common Stock in public offering, net of issuance costs of $920
Issuance of stock from RSUs, net
From December 31, 2017 to December 31, 2018
Issuance of stock from RSUs, net
The 1-for-5 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 102,380,238 shares to approximately 20,470,047 shares.Immediately after the annual meeting, the Board of Directors approved the reverse stock split of BIOLASE's common stock, through an amendment to BIOLASE's charter, at a ratio of 1 post-split share for every 5 pre-split shares. The 1-for-5 reverse stock split will become effective at 11:59 p.m. ET on Thursday, May 10, 2018 (the "Effective Date"), and Company common stock will begin trading on a split-adjusted basis at the opening of the market on May 11, 2018.
On September 29, 2017, we filed a registration statement on Form S-1 with the SEC for a rights offering in which our existing stockholders were to receive non-transferable subscription rights to purchase up to $12.0 million of additional shares of our common stock. The registration statement for the rights offering was declared effective on November 8, 2017 by the SEC. We completed the rights offering on December 5, 2017 and raised approximately $12.0 million by selling 26,302,703 shares of our common stock at the $0.456 per share offering price. As a result, the total number of shares of our common stock outstanding as of the completion of the rights offering was approximately 102,339,682 shares.
from December 31, 2016 to December 31, 2017
Issuance of stock from RSUs, net
Issuance of common stock upon conversion of Series D participating convertible preferred stock
Issuance of stock from rights offering, net
Issuance of Series D participating convertible preferred stock and warrants, net of issuance cost of $251
from December 31, 2015 to December 31, 2016
Issuance of common stock upon conversion of Series C participating convertible preferred stock
Issuance of stock from RSUs, net
Issuance of Series C participating convertible preferred stock and warrants, net of issuance cost of $480
from December 31, 2014 to December 31, 2015
Exercise of stock options, net
from December 31, 2013 to December 31, 2014
Exercise of stock options, net
Retirement of treasury stock
Issuance of stock, net
Exercise of warrants
Stock dividends
Common stock dividend: 0.005 shares per share
From December 31,2012 to December 31,2013
Issuance of stock, net
Exercise of warrants
Stock dividends
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.005 shares per share
from December 31, 2011 to December 31, 2012
Exercise of stock options, net
Stock repurchase
Exercise of warrants
Stock dividends
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.005 shares per share
Common stock dividend: 0.01 shares per share
Common stock dividend: 0.01 shares per share
Common stock dividend: 0.01 shares per share
Common stock dividend: 0.01 shares per share
Exercise of stock options, net
Exercise of stock options, net
from December 31, 2007 to December 31, 2008
Exercise of stock options, net
from December 31, 2006 to December 31, 2007
Exercise of stock options
from December 31, 2005 to December 31, 2006
Exercise of stock options
from December 31, 2004 to December 31, 2005
Exercise of stock options
Issuance of common stock
from December 31, 2003 to December 31, 2004
Exercise of stock options
Issuance of common stock
Treasury stock
from December 31, 2002 to December 31, 2003
Exercise of stock options
Exercise of warrants
Acquisition of ADL
from December 31, 2001 to December 31, 2002
Exercise of stock options
Exercise of warrants
from December 31, 2000 to December 31, 2001
Issuance of stock and warrants for earned services
Exercise of stock options
Exercise of warrants
from December 31, 1999 to December 31, 2000
Private placement of common stock, net
Issuance of stock and warrants for earned services
Cancellation of stock
Exercise of stock options
Issuance of shares for fractional interest on reverse split
from December 31, 1998 to December 31, 1999
Private placement of common stock, net
Issuance of stock and warrants for earned services
Exercise of stock options
Issuance of shares for fractional interest on reverse split
from December 31, 1997 to December 31, 1998
Private placement of common stock
Issuance of stock for Laser Skin Toner purchase
Issuance of stock and warrants for earned services
Exercise of stock options
Issuance of shares for fractional interest on reverse split
from December 31, 1996 to December 31, 1997
Private placement of common stock
Exercise of stock options
Issuance of stock primarily for services
Issuance of stock primarily for unearned services
Cancellation of previously issued stock
Conversion of preferred stock to common stock
Issuance of shares for fractional interest on reverse split
from December 31, 1995 to December 31, 1996
Exercise of stock options
Conversion of preferred stock to common stock
Issuance of shares for fractional interest on reverse split
Private placement of preferred stock